Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(15/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(15/week)
News
United States
(534/week)
Manufacturing
(381/week)
Energy
(301/week)
Technology
(425/week)
Other Manufacturing
(319/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Nonsteroidal antiandrogens
Jun 21, 2019
ESSA Pharma to Hold Annual Shareholders' Meeting and Announces Three Realm-Nominated Directors
Jun 14, 2019
Global Epoxy Resins Market Analysis, Trends and Forecasts Through 2015-2022 - Myriad Attributes Drive Demand for Waterborne Epoxy Resins in Coatings - ResearchAndMarkets.com
May 31, 2019
ERLEADA® (apalutamide) Significantly Improved Overall Survival (OS) and Radiographic Progression-Free Survival (rPFS) in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
May 10, 2019
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2019
May 04, 2019
Preclinical Data Highlighting Therapeutic Potential of EPI-7386 Presented at 2019 American Urological Association Annual Meeting
Apr 29, 2019
U.S. FDA accepts New Drug Application and grants Priority Review for darolutamide
Apr 25, 2019
ESSA Pharma to Attend Bloom Burton & Co. Healthcare Investor Conference 2019
Apr 17, 2019
ESSA Pharma Announces Abstract Presentation at the 2019 American Urological Association Annual Meeting
Apr 13, 2019
Global Bisphenol A (BPA) Market Outlook and Forecasts 2019-2023 - ResearchAndMarkets.com
Apr 12, 2019
ESSA Pharma Grants Stock Options
Apr 09, 2019
Global $2.64 Bn HBPA Epoxy Resin Market Outlook 2017-2019 & Forecast to 2026 - ResearchAndMarkets.com
Mar 28, 2019
ESSA Pharma Announces Nomination of EPI-7386 as Lead Clinical Candidate in Metastatic Castration-Resistant Prostate Cancer
Mar 18, 2019
ESSA Pharma to Present at the Oppenheimer 29th Annual Healthcare Conference
Mar 14, 2019
ESSA Pharma to Attend the 31st Annual ROTH Conference
Mar 13, 2019
Large Prospective Trial Validates Detection of AR-V7 Biomarker Using Epic Sciences' Platform to Predict Treatment Outcomes for Patients with Advanced Prostate Cancer
Feb 11, 2019
ESSA Pharma Announces Two Abstracts Selected to be Presented at the 2019 Genitourinary Cancers Symposium
Feb 11, 2019
Phase 3 ARCHES Trial Shows XTANDI® (enzalutamide) Significantly Improved Radiographic Progression-Free Survival in Men with Metastatic Hormone-Sensitive Prostate Cancer
Dec 20, 2018
Astellas and Pfizer Announce Positive Top-Line Results from Phase 3 ARCHES Trial of XTANDI® (enzalutamide) in Men with Metastatic Hormone-Sensitive Prostate Cancer
Nov 06, 2018
New Clinical Oncology Collaboration Between Nektar and Pfizer to Evaluate Combination of NKTR-214, a CD122-Biased Agonist, with Avelumab and Talazoparib or Enzalutamide in Multiple Cancers
Oct 24, 2018
Phase III Trial of Darolutamide in Patients with Non-metastatic Castration-resistant Prostate Cancer Meets Primary Endpoint
‹‹
Page 3
››
Latest News
May 1, 2024
Valaris Issues Fleet Status Report
May 1, 2024
Kolibri Global Energy Inc. Provides Update on 2023 Annual Filings
May 1, 2024
Leeward Renewable Energy Operations Announces the Posting of Year End 2023 Financial Results and May 10...
May 1, 2024
Itron Enhances Temetra® Platform to Maximize Business Value for Water Utilities in Australia and New Zealand
May 1, 2024
Imperial reports voting results for election of directors
May 1, 2024
Microvast Schedules First Quarter Earnings Call
May 1, 2024
Magellan Aerospace Announces Quarterly Dividend
May 1, 2024
Magellan Aerospace Announces Report on Voting Results for Directors
View all News
Agenda
29
October
United Kingdom
Copthorne Tara Hotel, London, UK
International Dismounted Soldier, 29-30 October 2024, Copthorne Tara Hotel, London, UK
Navigating the Evolving Battlespace: Enhancing the Capabilities of the Dismounted Soldier The modern battlefield...
24
September
United Kingdom
Hilton London Syon Park, London, UK
Defence Transformation Conference, 24-26 September 2024, Hilton London Syon Park, London, UK
Returning for its 8th year, Defence Transformation 2024 will feature an updated format that will address all aspects of...
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
View All Events